Australia markets closed

3D Medicines Inc. (1244.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
6.700-0.180 (-2.62%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.78B
Enterprise value 1.00B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)1.76
Enterprise value/revenue 1.58
Enterprise value/EBITDA -1.81

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-90.00%
S&P500 52-week change 322.43%
52-week high 3131.500
52-week low 34.680
50-day moving average 36.217
200-day moving average 313.731

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 3965.85k
Shares outstanding 5258.18M
Implied shares outstanding 6258.18M
Float 8157.73M
% held by insiders 143.05%
% held by institutions 12.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -82.64%
Operating margin (ttm)-136.01%

Management effectiveness

Return on assets (ttm)-26.89%
Return on equity (ttm)-63.70%

Income statement

Revenue (ttm)634.95M
Revenue per share (ttm)2.78
Quarterly revenue growth (yoy)-21.60%
Gross profit (ttm)N/A
EBITDA -585.97M
Net income avi to common (ttm)-524.7M
Diluted EPS (ttm)-2.480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)996.58M
Total cash per share (mrq)4.29
Total debt (mrq)282.42M
Total debt/equity (mrq)32.44%
Current ratio (mrq)2.19
Book value per share (mrq)4.03

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A